Bank of New York Mellon’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $33.6M | Sell |
|
|||||
|
2025
Q2 | $28.2M | Buy |
|
|||||
|
2025
Q1 | $24.7M | Sell |
|
|||||
|
2024
Q4 | $35.7M | Buy |
|
|||||
|
2024
Q3 | $28M | Sell |
|
|||||
|
2024
Q2 | $26M | Sell |
|
|||||
|
2024
Q1 | $23.1M | Sell |
|
|||||
|
2023
Q4 | $19.5M | Sell |
|
|||||
|
2023
Q3 | $19.4M | Buy |
|
|||||
|
2023
Q2 | $14.2M | Buy |
|
|||||
|
2023
Q1 | $16M | Sell |
|
|||||
|
2022
Q4 | $17M | Buy |
|
|||||
|
2022
Q3 | $15M | Buy |
|
|||||
|
2022
Q2 | $13.8M | Sell |
|
|||||
|
2022
Q1 | $17.6M | Buy |
|
|||||
|
2021
Q4 | $14.8M | Buy |
|
|||||
|
2021
Q3 | $17.5M | Buy |
|
|||||
|
2021
Q2 | $17.4M | Sell |
|
|||||
|
2021
Q1 | $22.4M | Sell |
|
|||||
|
2020
Q4 | $19.3M | Sell |
|
|||||
|
2020
Q3 | $18.2M | Sell |
|
|||||
|
2020
Q2 | $24.9M | Buy |
|
|||||
|
2020
Q1 | $17M | Sell |
|
|||||
|
2019
Q4 | $18.8M | Sell |
|
|||||
|
2019
Q3 | $13.7M | Buy |
|
|||||
|
2019
Q2 | $18.1M | Buy |
|
|||||
|
2019
Q1 | $28.7M | Sell |
|
|||||
|
2018
Q4 | $30.5M | Buy |
|
|||||
|
2018
Q3 | $41.1M | Sell |
|
|||||
|
2018
Q2 | $47.4M | Buy |
|
|||||
|
2018
Q1 | $33.2M | Sell |
|
|||||
|
2017
Q4 | $39.8M | Sell |
|
|||||
|
2017
Q3 | $263M | Sell |
|
|||||
|
2017
Q2 | $606M | Sell |
|
|||||
|
2017
Q1 | $622M | Sell |
|
|||||
|
2016
Q4 | $715M | Buy |
|
|||||
|
2016
Q3 | $742M | Buy |
|
|||||
|
2016
Q2 | $747M | Buy |
|
|||||
|
2016
Q1 | $690M | Buy |
|
|||||
|
2015
Q4 | $600M | Buy |
|
|||||
|
2015
Q3 | $386M | Buy |
|
|||||
|
2015
Q2 | $309M | Sell |
|
|||||
|
2015
Q1 | $355M | Buy |
|
|||||
|
2014
Q4 | $303M | Sell |
|
|||||
|
2014
Q3 | $307M | Sell |
|
|||||
|
2014
Q2 | $430M | Sell |
|
|||||
|
2014
Q1 | $441M | Sell |
|
|||||
|
2013
Q4 | $348M | Buy |
|
|||||
|
2013
Q3 | $206M | Buy |
|
|||||
|
2013
Q2 | $208M | Buy |
|